Oil and Natural Gas Corporation (ONGC) has received a compliance certificate from Alankit Assignments Limited, the Registrar & Share Transfer Agent, for the quarter ended September 30, 2025. The certificate confirms compliance with the provisions of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.

Compliance Confirmation

ONGC has received confirmation of compliance with regulatory requirements for the Q2 2025 period. This relates to regulations concerning depositories and participants, as stipulated by SEBI.

Details of the Certificate

The certificate, issued by Alankit Assignments Limited, confirms that all share certificates received for dematerialization during the quarter ending September 30, 2025, have been duly processed. Physical share certificates have been mutilated and cancelled after due verification, and depositories are now registered as owners in the company records.

This ensures that ONGC is in adherence to all regulatory standards concerning securities dematerialization.

Source: BSE

GlaxoSmithKline Pharmaceuticals Limited has received a certificate regarding the dematerialization of securities for the quarter ended September 30, 2025. The registrar and share transfer agent, Kfin Technologies Limited, confirmed that securities received for dematerialization have been processed and that necessary updates have been made to the register of members. This announcement was made on October 8, 2025.

Dematerialization Certificate Received

GlaxoSmithKline Pharmaceuticals Limited has received confirmation regarding the handling of securities during the quarter ending September 30, 2025. Kfin Technologies Limited, the registrar and share transfer agent, provided the certificate.

Key Points of the Certificate

The certificate confirms that all securities received for dematerialization during Q2 (Jul-Sep) 2025 have been duly processed. The depositories have accepted or rejected the securities as appropriate. Furthermore, the security certificates received for dematerialization have been mutilated and cancelled after verification. The names of the depositories have been updated in the register of members.

This announcement was officially released on October 8, 2025.

Source: BSE

Triveni Turbine has received a certificate regarding the dematerialization of equity shares for the quarter ended September 30, 2025. The certificate confirms that all physical share certificates received for dematerialization have been duly processed. This ensures compliance with SEBI regulations and maintenance of accurate records.

Share Dematerialization Confirmation

Triveni Turbine confirms the successful processing of share dematerialization requests for the quarter ending September 30, 2025. The certificate, received from Alankit Assignments Limited, the Registrar and Share Transfer Agent, ensures adherence to regulatory requirements.

Key Details of Certification

The certificate verifies that all physical share certificates submitted for dematerialization have been listed on the stock exchanges. These certificates have undergone verification, subsequent mutilation, and cancellation. Furthermore, the depository’s name has been accurately substituted in the company’s records as the registered owner.

This process maintains transparency and facilitates efficient record-keeping of share ownership. The certificate, dated October 7, 2025, confirms the completion of this important activity.

Source: BSE

DB Realty has received a certificate confirming compliance with SEBI regulations for depositories and participants for Q2 2025 (July-September). The certificate, provided by MUFG Intime India Private Limited, confirms that securities received for dematerialization during the quarter have been duly processed and reconciled with depository records. This ensures regulatory adherence and transparency in handling shareholder securities.

Certificate of Compliance

DB Realty has obtained a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for Q2 2025 (July-September).

Details of Compliance

The certificate, provided by MUFG Intime India Private Limited, confirms that securities received from depository participants for dematerialization during the quarter have been confirmed and reconciled. Furthermore, the security certificates received for dematerialization have been mutilated and cancelled after due verification. There were no requests received from the shareholders for the quarter ended September 30, 2025.

Source: BSE

Titan Company Limited has announced a change in the e-mail address of its Registrar and Share Transfer Agent (RTA), MUFG Intime India Private Limited. The updated e-mail address for investor communications is [email protected], effective from October 1, 2025. Other contact details, including the website, telephone, and fax numbers, remain unchanged.

Registrar and Share Transfer Agent Contact Update

Titan Company Limited informs its stakeholders of a change regarding the contact information for its Registrar and Share Transfer Agent (RTA), MUFG Intime India Private Limited. This change is specifically related to the e-mail address used for investor communications.

Updated E-mail Address

The new e-mail address for contacting MUFG Intime India Private Limited regarding RTA matters is [email protected]. This change is effective from October 1, 2025. Investors are requested to use this new e-mail address for all future correspondence.

Other Contact Details

Please note that the other contact details for MUFG Intime India Private Limited, including their registered office address, website (https://in.mpms.mufg.com/), telephone number (+91 810 811 8484), and fax number (+91 22 4918 6060), remain unchanged.

MUFG Intime India Private Limited Contact Information

Registered Office: MUFG Intime India Private Limited, C-101, Embassy 247, L.B.S. Marg, Vikhroli (West), Mumbai – 400 083.

Telephone: +91 810 811 8484

Fax: +91 22 4918 6060

Website: https://in.mpms.mufg.com/

Source: BSE

Ajanta Pharma has submitted its Sustainability Report for the financial year 2025, prepared in accordance with Global Reporting Initiative (GRI) Standards. This voluntary report supplements the previously submitted Business Responsibility and Sustainability Report (BRSR), outlining the company’s progress across environmental, social, and governance (ESG) parameters. The report highlights Ajanta Pharma’s commitment to responsible and sustainable growth.

Sustainability Report Submission

Ajanta Pharma has announced the submission of its Sustainability Report for the financial year 2025. The report was prepared following the standards set by the Global Reporting Initiative (GRI). This report offers additional insights into Ajanta Pharma’s dedication to sustainable and responsible business practices, going beyond regulatory compliance. This latest report is in addition to the Business Responsibility and Sustainability Report (BRSR) that was submitted earlier.

Key Areas of Focus

The Sustainability Report highlights various initiatives undertaken by Ajanta Pharma, focusing on achievements and progress made in key areas:

• Environmental Impact: Details on the company’s effort to minimize its ecological footprint.
• Social Responsibility: Insight into the company’s impact on society through various social initiatives.
• Governance Practices: Shows high standards of corporate governance and ethical practices.

This submission underscores Ajanta Pharma’s continuous commitment to sustainable growth by integrating responsible practices and setting benchmarks within the pharmaceutical industry.

Source: BSE

Cohance Lifesciences Limited confirms that all details of securities dematerialized or rematerialized during the quarter ended September 30, 2025, have been duly furnished to all stock exchanges. This confirmation is as per Regulation 74(5) of the SEBI regulations and is provided by KFin Technologies Limited, the Registrar and Share Transfer Agent. The Company ensures compliance with regulatory requirements concerning dematerialization processes.

Dematerialization Compliance

Cohance Lifesciences Limited has received confirmation regarding compliance with dematerialization regulations for Q2 FY26. The certificate, provided by KFin Technologies Limited, verifies that all necessary details regarding the dematerialization or rematerialization of securities during the quarter ended September 30, 2025, have been accurately and promptly furnished to the relevant stock exchanges.

Confirmation from Registrar

KFin Technologies Limited, the Registrar and Share Transfer Agent for Cohance Lifesciences, has issued the confirmation certificate. This certificate affirms that the company has met its obligations under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, ensuring transparency and adherence to regulatory standards in securities processing.

Regulatory Compliance

This announcement confirms Cohance Lifesciences’ commitment to maintaining high standards of corporate governance and complying with all applicable regulatory requirements related to securities transactions. The company’s proactive approach to compliance ensures the integrity and transparency of its operations.

Source: BSE

Star Health and Allied Insurance Company has announced the receipt of compliance certificates from its Registrar and Transfer Agent, Kfin Technologies Limited, for the quarter ended September 30, 2025. These certificates confirm compliance with SEBI regulations and have been submitted to both the BSE and NSE for informational purposes. The details are also available on the company’s website.

Compliance Confirmation

Star Health and Allied Insurance Co. Ltd. has received the necessary compliance certificates for Q2 2025-26 (July-September) from Kfin Technologies Limited, the company’s Registrar and Transfer Agent.

Regulatory Filing

The compliance certificates, which pertain to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, have been submitted to the Bombay Stock Exchange (BSE) and the National Stock Exchange of India (NSE). This filing ensures transparency and adherence to regulatory requirements.

About Kfin Technologies Certificates

These certificates confirm that all securities dematerialized or rematerialized during the quarter ended September 30, 2025, have been duly processed and that the details have been furnished to all relevant stock exchanges.

Source: BSE